|
CCNDBP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.942200E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.157400E-01 |
| Normal-vs-Stage2 |
8.705800E-01 |
| Normal-vs-Stage3 |
4.818600E-04 |
| Normal-vs-Stage4 |
1.381130E-04 |
| Stage1-vs-Stage2 |
9.303800E-01 |
| Stage1-vs-Stage3 |
1.88591999999987E-05 |
| Stage1-vs-Stage4 |
2.17960000004069E-06 |
| Stage2-vs-Stage3 |
6.056400E-03 |
| Stage2-vs-Stage4 |
2.641500E-03 |
| Stage3-vs-Stage4 |
4.296800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.475700E-02 |
| Normal-vs-AfricanAmerican |
1.007630E-02 |
| Normal-vs-Asian |
6.896000E-01 |
| Caucasian-vs-AfricanAmerican |
2.077600E-01 |
| Caucasian-vs-Asian |
7.897000E-01 |
| AfricanAmerican-vs-Asian |
4.213200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.295900E-02 |
| Normal-vs-Female |
6.150000E-02 |
| Male-vs-Female |
9.761200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.582300E-02 |
| Normal-vs-Age(41-60Yrs) |
1.305840E-01 |
| Normal-vs-Age(61-80Yrs) |
4.882200E-02 |
| Normal-vs-Age(81-100Yrs) |
5.127200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.688800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.927800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.091200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.389800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.098800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.114000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.949760E-01 |
| Normal-vs-Grade 2 |
9.047800E-01 |
| Normal-vs-Grade 3 |
9.816200E-03 |
| Normal-vs-Grade 4 |
4.09070000095824E-08 |
| Grade 1-vs-Grade 2 |
2.018600E-01 |
| Grade 1-vs-Grade 3 |
1.558050E-02 |
| Grade 1-vs-Grade 4 |
3.77320000000125E-05 |
| Grade 2-vs-Grade 3 |
4.637200E-04 |
| Grade 2-vs-Grade 4 |
9.13730202611873E-11 |
| Grade 3-vs-Grade 4 |
1.786230E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.252200E-01 |
| Normal-vs-ccB subtype |
9.364900E-04 |
| ccA subtype-vs-ccB subtype |
5.21770000538879E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.828970E-01 |
| Normal-vs-N1 |
1.070410E-02 |
| N0-vs-N1 |
9.333900E-02 |
|
|
